RIZZARI, CARMELO
RIZZARI, CARMELO
DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)
Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster-based intensive chemotherapy. The Associazione Italiana di Ematologia ed Oncologia Pediatrica
1995 Conter, V; Aricò, M; Valsecchi, M; Rizzari, C; Testi, A; Messina, C; Mori, P; Miniero, R; Colella, R; Basso, G
Prognostic value of nephromegaly at diagnosis of childhood acute lymphoblastic leukemia
1995 D'Angelo, P; Mura, R; Rizzari, C; Conter, V; Bellini, F; Valsecchi, M; Manganini, C; Silvestri, D; Masera, G
Role of cranial radiotherapy for childhood T-cell acute lymphoblastic leukemia with high WBC count and good response to prednisone. Associazione Italiana Ematologia Oncologia Pediatrica and the Berlin-Frankfurt-Münster groups
1997 Conter, V; Schrappe, M; Aricó, M; Reiter, A; Rizzari, C; Dördelmann, M; Valsecchi, M; Zimmermann, M; Ludwig, W; Basso, G; Masera, G; Riehm, H
MTHFR 677C-->T mutation and neural-tube defects
1997 Rizzari, C; Valsecchi, M; Conter, V
Intensive BFM chemotherapy for childhood ALL: interim analysis of the AIEOP-ALL 91 study. Associazione Italiana Ematologia Oncologia Pediatrica
1998 Conter, V; Aricò, M; Valsecchi, M; Rizzari, C; Testi, A; Miniero, R; Di Tullio, M; Lo Nigro, L; Pession, A; Rondelli, R; Messina, C; Santoro, N; Mori, P; De Rossi, G; Tamaro, P; Silvestri, D; Biondi, A; Basso, G; Masera, G
Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) acute lymphoblastic leukemia studies, 1982-1995
2000 Conter, V; Aricò, M; Valsecchi, M; Basso, G; Biondi, A; Madon, E; Mandelli, F; Paolucci, G; Pession, A; Rizzari, C; Rondelli, R; Zanesco, L; Masera, G
Effect of protracted high-dose L-asparaginase given as a second exposure in a Berlin-Frankfurt-Münster-based treatment: results of the randomized 9102 intermediate-risk childhood acute lymphoblastic leukemia study--a report from the Associazione Italiana Ematologia Oncologia Pediatrica
2001 Rizzari, C; Valsecchi, M; Aricò, M; Conter, V; Testi, A; Barisone, E; Casale, F; Lo Nigro, L; Rondelli, R; Basso, G; Santoro, N; Masera, G
Improved outcome in high-risk childhood acute lymphoblastic leukemia defined by prednisone-poor response treated with double Berlin-Frankfurt-Muenster protocol II
2002 Aricò, M; Valsecchi, M; Conter, V; Rizzari, C; Pession, A; Messina, C; Barisone, E; Poggi, V; De Rossi, G; Locatelli, F; Micalizzi, M; Basso, G; Masera, G
Genotypes of the glutathione S-transferase superfamily do not correlate with outcome of childhood acute lymphoblastic leukemia
2003 Sala, A; Lanciotti, M; Valsecchi, M; di Michele, P; Dufour, C; Haupt, G; Rizzari, C; Biondi, A
FLT3 internal tandem duplication in childhood acute myeloid leukaemia: association with hyperleucocytosis in acute promyelocytic leukaemia
2003 Arrigoni, P; Beretta, C; Silvestri, D; Rossi, V; Rizzari, C; Valsecchi, M; Cazzaniga, G; Biondi, A
Outcome of very late relapse in children with acute lymphoblastic leukemia
2004 Rizzari, C; Valsecchi, M; Aricò, M; Miniero, R; Messina, C; De Rossi, G; Testi, A; Mura, R; Galimberti, S; Biondi, A; Locatelli, F; Conter, V
Development of a quantitative-PCR method for specific FLT3/ITD monitoring in acute myeloid leukemia
2004 Beretta, C; Gaipa, G; Rossi, V; Bernasconi, S; Spinelli, O; Dell'Oro, M; Rizzari, C; Rambaldi, A; Biondi, A; Cazzaniga, G
Treatment reduction in highly selected standard-risk childhood acute lymphoblastic leukemia. The AIEOP ALL-9501 study
2005 Aricò, M; Conter, V; Valsecchi, M; Rizzari, C; Boccalatte, M; Barisone, E; Messina, C; De Rossi, G; Lo Nigro, L; Pession, A; Locatelli, F; Micalizzi, C; Basso, G; Masera, G
Ischemic stroke in children treated for acute lymphoblastic leukemia: a retrospective study
2005 Santoro, N; Giordano, P; Del Vecchio, G; Guido, G; Rizzari, C; Varotto, S; Masera, G; De Mattia, D
Long-term results of a randomized trial on extended use of high dose L-asparaginase for standard risk childhood acute lymphoblastic leukemia
2005 Pession, A; Valsecchi, M; Masera, G; Kamps, W; Magyarosy, E; Rizzari, C; van Wering, E; Lo Nigro, L; van der Does, A; Locatelli, F; Basso, G; Aricò, M
Role of treatment intensification in infants with acute lymphoblastic leukemia: results of two consecutive AIEOP studies
2006 Biondi, A; Rizzari, C; Valsecchi, M; De Lorenzo, P; Aricò, M; Basso, G; Locatelli, F; Lo Nigro, L; De Rossi, G; Masera, G
Are genotypes of glutathione S-transferase superfamily a risk factor for childhood acute lymphoblastic leukemia? Results of an Italian case-control study
2007 Pigullo, S; Haupt, R; Dufour, C; Di Michele, P; Valsecchi, M; Basso, G; Rizzari, C; Biondi, A; Lanciotti, M
Role of DNA index in childhood acute lymphoblastic leukemia treated with BFM based therapy: Long term results of the AIEOP-ALL 95
2007 Rizzari, C; Conter, V; Valsecchi, M; Barisone, E; Casale, F; De Rossi, G; Lo Nigro, L; Locatelli, F; Messina, C; Micalizzi, C; Parasole, R; Pession, A; Santoro, N; Testi, A; Biondi, A; Rondelli, R; Silvestri, D; Basso, G; Masera, G; Arico, M
Long-term results of the AIEOP-ALL-95 Trial for Childhood Acute Lymphoblastic Leukemia: insight on the prognostic value of DNA index in the framework of Berlin-Frankfurt-Muenster based chemotherapy
2008 Aricò, M; Valsecchi, M; Rizzari, C; Barisone, E; Biondi, A; Casale, F; Locatelli, F; Lo Nigro, L; Luciani, M; Messina, C; Micalizzi, C; Parasole, R; Pession, A; Santoro, N; Testi, A; Silvestri, D; Basso, G; Masera, G; Conter, V
Minimal residual disease is an important predictive factor of outcome in children with relapsed 'high-risk' acute lymphoblastic leukemia
2008 Paganin, M; Zecca, M; Fabbri, G; Polato, K; Biondi, A; Rizzari, C; Locatelli, F; Basso, G